Antimicrobial susceptibility of standard strains of nontuberculous mycobacteria by microplate Alamar Blue assay

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Li, Guilian ^a,b   Lian, Lu Lu ^a,c   Wan, Li ^a   Zhang, Jingrui ^a,d   Zhao, Xiuqin ^a,b   Jiang, Yi ^a,b   Zhao, Li Li ^a,b   Liu, Haican ^a,b   Wan, Kanglin ^a,b,c,d  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH CHINA   (China)

^d WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-BACTERIAL AGENTS; MICROBIAL SENSITIVITY TESTS; NONTUBERCULOUS MYCOBACTERIA; OXAZINES; SPECIES SPECIFICITY; XANTHENES;

EID: 84893559645     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084065     Document Type: Article

References (27)

1. World health organization. Global tuberculosis control: WHO report 2011.
2. Richter E, Rusch-Gerdes S, Hillemann D (2006) Evaluation of the GenoType Mycobacterium Assay for identification of mycobacterial species from cultures. J Clin Microbiol 44: 1769-1775. (Pubitemid 43726267)
3. Bicmen C, Gunduz AT, Coskun M, Senol G, Cirak AK, et al. (2011) Molecular detection and identification of mycobacterium tuberculosis complex and four clinically important nontuberculous mycobacterial species in smear-negative clinical samples by the genotype mycobacteria direct test. J Clin Microbiol 49: 2874-2878.
4. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, Nocardiae and other aerobic actinomycetes; approved standard. Document M24-A.Wayne, PA: NCCLS; 2003.
5. Garcia-Agudo L, Garcia-Martos P, Jesus I, Rodriguez-Iglesias M (2009) Assessment of in vitro susceptibility to antimicrobials of rapidly growing mycobacteria by E-test. Rev Med Chil 137: 912-917.
6. van Ingen J, van der Laan T, Dekhuijzen R, Boeree M, van Soolingen D (2010) In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands. Int J Antimicrob Agents 35: 169-173.
7. Gayathri R, Therese KL, Deepa P, Mangai S, Madhavan HN (2010) Antibiotic susceptibility pattern of rapidly growing mycobacteria. J Postgrad Med 56: 76-78.
8. Aubry A, Jarlier V, Escolano S, Truffot-Pernot C, Cambau E (2000) Antibiotic susceptibility pattern of Mycobacterium marinum. Antimicrob Agents Chemother 44: 3133-3136.
9. Leonard B, Coronel J, Siedner M, Grandjean L, Caviedes L, et al. (2008) Interand intra-assay reproducibility of microplate Alamar blue assay results for isoniazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 46: 3526-3529.
10. Chauca JA, Palomino JC, Guerra H (2007) Evaluation of the accuracy of the microplate Alamar Blue assay for rapid detection of MDR-TB in Peru. Int J Tuberc Lung Dis 11: 820-822. (Pubitemid 47056995)
11. Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. World Health Organization, Geneva, 2008.
12. Vanitha JD, Paramasivan CN (2004) Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates. Diagn Microbiol Infect Dis 49: 179-182. (Pubitemid 38891724)
13. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, et al. (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416.
14. Yang SC, Hsueh PR, Lai HC, Teng LJ, Huang LM, et al. (2003) High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother 47: 1958-1962.
15. Bicmen C, Coskun M, Gunduz AT, Senol G, Cirak AK, et al. (2010) Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not? New Microbiol 33: 399-403.
16. Brown-Elliott BA, Wallace RJ Jr (2002) Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 15: 716-746. (Pubitemid 41199631)
17. Fernandez-Roblas R, Martin-de-Hijas NZ, Fernandez-Martinez AI, Garcia-Almeida D, Gadea I, et al. (2008) In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria. Antimicrob Agents Chemother 52: 4184-4186.
18. Shen GH, Wu BD, Wu KM, Chen JH (2007) In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother 51: 1849-1851.
19. Petrini B (2006) Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS 114: 319-328.
20. Colombo RE, Olivier KN (2008) Diagnosis and treatment of infections caused by rapidly growing mycobacteria. Semin Respir Crit Care Med 29: 577-588.
21. Huang YC, Liu MF, Shen GH, Lin CF, Kao CC, et al. (2010) Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing. J Microbiol Immunol Infect 43: 401-406.
22. Park S, Kim S, Park EM, Kim H, Kwon OJ, et al. (2008) In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea. J Korean Med Sci 23: 49-52.
23. Wallace RJ Jr, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW (2002) Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 46: 3164-3167.
24. Wallace RJ Jr, Bedsole G, Sumter G, Sanders CV, Steele LC, et al. (1990) Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother 34: 65-70. (Pubitemid 20019965)
25. Wallace RJ Jr, Brown BA, Onyi GO (1991) Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 35: 773-775.
26. David S (2001) Synergic activity of D-cycloserine and beta-chloro-D-alanine against Mycobacterium tuberculosis. J Antimicrob Chemother 47: 203-206.
27. Cavusoglu C, Gurpinar T, Ecemis T (2012) Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel. New Microbiol 35: 73-76.